Cellyan Biotechnology Co., Ltd

The company operates in two main business categories: OTC pharmaceutical cross-border e-commerce supply chain services and OTC pharmaceutical cross-border procurement and distribution. The Supply Chain Services division, primarily run through its Hong Kong subsidiary, Joint Cross Border, focuses on providing third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market. According to the F&S Report, Joint Cross Border ranked first in this sector by revenue in 2022. This division offers a comprehensive one-stop solution for Mainland Chinese customers seeking cross-border OTC pharmaceutical products. Services include pre-consultation, product information review, procuring overseas OTC pharmaceutical products, enlisting products with the HKDOH, obtaining import and export permits and clearances, warehousing, packaging, and arranging logistics and end-to-end delivery. The Procurement and Distribution division, primarily conducted through its Hong Kong subsidiary, V-Alliance, handles the cross-border procurement and distribution of OTC pharmaceuticals. Joint Cross Border aims to address the inefficiencies of traditional supply chains in navigating varied international regulations for OTC pharmaceutical products, meeting the demand from Mainland Chinese consumers for overseas products.